USP 800: DRUGS OF CONCERN IN THE COMMUNITY

PHARMACY

SATURDAY/11:30AM-12:30PM

ACPE UAN: 0107-9999-18-302-L07-P 0.1 CEU/1.0 hr

0107-9999-18-302-L07-T 0.1 CEU/1.0 hr

Activity Type: Knowledge-Based

Learning Objectives for Pharmacists & Pharmacy Technicians:

Upon completion of this CPE activity participants should be able to:

1. Identify drugs that must be handled as hazardous.

2. Describe the responsibilities of the designated person.

3. Determine when an assessment of risk approach may be used.

4. List required policies and procedures.

5. Describe staff training and competency requirements.

Speaker: Brenda Jensen, CPhT, CNMT, MBA

Brenda’s pharmacy experience began in 1984 as a pharmacy specialist in the US Air

Force, and she has been involved in pharmacy one way or another since then (including

community and hospital pharmacy, nonsterile and sterile compounding, oncology and

nuclear pharmacy). She is an owner at Compounding Consultants, LLC located in Sioux

Falls, SD. Brenda has helped over 250 pharmacies in 45 states improve compounding

quality and safety. She assists with PCAB accreditation, NABP VPP or UCAP credentialing,

development of standard operating procedures, USP and/or state law compliance, and

provides onsite training to compounding personnel. She is a member of multiple

pharmacy-related organizations and is currently the vice-chair of the APhA Compounding Special Interest Group

and serves on the International Academy of Compounding Pharmacists Foundation Board of Directors and

American College of Veterinary Pharmacists Board of Directors.

Speaker Disclosure: Brenda Jensen reports no actual or potential conflicts of interest in relation to this CPE

activity. Off-label use of medications will not be discussed during this presentation.

1/23/2019

1

Presented by:

USP 800: Drugs of Concern in the Community Pharmacy

Brenda Jensen CPhT, CNMT, MBA

Learning Objectives

Upon successful completion of this activity, participants should be able to:

• Identify drugs that must be handled as hazardous.

• Describe the responsibilities of the designated person.

• Determine when an assessment of risk approach may be used.

• List required policies and procedures.

• Describe staff training and competency requirements.

1

2

1/23/2019

2

Disclosure

Brenda Jensen reports no actual or potential conflicts of interest associated with this presentation. The views and opinions expressed are those of the speaker and are not endorsed by or affiliated with USP.

3

4

1/23/2019

3

5

6

1/23/2019

4

7

8

1/23/2019

5

9

10

1/23/2019

6

11

12

1/23/2019

7

13

14

1/23/2019

8

15

16

1/23/2019

9

17

18

1/23/2019

10

19

20

1/23/2019

11

21

22

1/23/2019

12

23

24

1/23/2019

13

25

26

1/23/2019

14

27

28

1/23/2019

15

The NIOSH list is divided into categories that include all of the following except

A. Antineoplastic

B. Reproductive hazard

C. Poison

D. Non-antineoplastic HD

29

30

1/23/2019

16

The NIOSH list is divided into categories that include all of the following except

A. Antineoplastic

B. Reproductive hazard

C. Poison

D. Non-antineoplastic HD

The designated person must perform wipe sampling to ensure environmental control of the storage and dispensing areas.

A. True

B. False

C.

D

31

32

1/23/2019

17

The designated person must perform wipe sampling to ensure environmental control of the storage and dispensing areas.

A. True

B. False

C.

D

Drugs on the NIOSH list that do not have to follow all the containment requirements of <800> if an assessment of risk is performed and implemented include:

A. Any HD API

B. Any antineoplastic - manipulation

C. Final dosage forms - no manipulation

D. All of the above

33

34

1/23/2019

18

Drugs on the NIOSH list that do not have to follow all the containment requirements of <800> if an assessment of risk is performed and implemented include:

A. Any HD API

B. Any antineoplastic - manipulation

C. Final dosage forms - no manipulation

D. All of the above

The hazardous drug receiving area must have

A. Negative pressure

B. Positive pressure

C. Neutral pressure

D. A or C

35

36

1/23/2019

19

The hazardous drug receiving area must have

A. Negative pressure

B. Positive pressure

C. Neutral pressure

D. A or C

70% IPA is used to clean countertops

A. True

B. False

C.

D.

37

38

1/23/2019

20

70% IPA is used to clean countertops

A. True

B. False

C.

D.

Take Home Points

• Identify a designated person.

• Create a list of HDs.

• Perform Assessments of Risk.

• Write policies and procedures

• Train staff and assess competency.

39

40

1/23/2019

21

Questions?

41